These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease A short commentary. Quinn NP J Neurol; 2003 Jan; 250(1):97. PubMed ID: 12528000 [No Abstract] [Full Text] [Related]
8. [Benefit of L-DOPA-without-DCI (decarboxylase inhibitor) therapy on wearing-off phenomenon in advanced stages of Parkinson's disease patients]. Hironishi M; Miwa H; Kondo T No To Shinkei; 2002 Feb; 54(2):127-32. PubMed ID: 11889758 [TBL] [Abstract][Full Text] [Related]
9. Treatments for Parkinson's disease. Health News; 2000 Jun; 6(6):8. PubMed ID: 10865523 [No Abstract] [Full Text] [Related]
11. Selegiline: a second look. Six years later: too risky in Parkinson's disease. Prescrire Int; 2002 Aug; 11(60):108-11. PubMed ID: 12199263 [TBL] [Abstract][Full Text] [Related]
12. New drugs for Parkinson's disease. Med Lett Drugs Ther; 1976 Dec; 18(27):117-8. PubMed ID: 1004371 [No Abstract] [Full Text] [Related]
13. Deprenyl in Parkinson's disease. Korczyn AD; Nisipeanu P Ann Neurol; 1996 Aug; 40(2):268-9. PubMed ID: 8773617 [No Abstract] [Full Text] [Related]
14. Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test. Fabbrini G; Barbanti P; Aurilia C; Pauletti C; Meco G Funct Neurol; 2002; 17(4):199-201. PubMed ID: 12675263 [TBL] [Abstract][Full Text] [Related]
15. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia. Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733 [TBL] [Abstract][Full Text] [Related]
16. Levodopa and the progression of Parkinson's disease. Walton-Hadlock JL N Engl J Med; 2005 Mar; 352(13):1386; author reply 1386. PubMed ID: 15800240 [No Abstract] [Full Text] [Related]
17. [Parkinson's disease: what therapeutic strategy is advisable in early stage disease?]. Destee A Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():109-18. PubMed ID: 10916045 [No Abstract] [Full Text] [Related]
18. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis. Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614 [TBL] [Abstract][Full Text] [Related]
19. Reevaluation of levodopa therapy for the treatment of advanced Parkinson's disease. Yokochi M Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S25-30. PubMed ID: 19131038 [TBL] [Abstract][Full Text] [Related]